The 'Information Document' has been prepared by Lytix Biopharma AS (the "Company") solely for use in connection with the admission to trading of the Company's shares on Euronext Growth Oslo. The first day of trading in the Company's shares on Euronext Growth Oslo is 14 June 2021. Arctic Securities AS and Sparebank 1 Markets AS have acted as Euronext Growth advisors for the Company and Advokatfirmaet Thommessen AS has acted as legal counsel to the Company in connection with the listing on Euronext Growth Oslo.

For further information please contact:
Gjest Breistein (CFO), telephone: +47 952 60 512, e-mail: Gjest.Breistein@lytixbiopharma.com